相似文献
1
Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.
Br J Clin Pharmacol. 1981 Sep;12(3):429-31. doi: 10.1111/j.1365-2125.1981.tb01240.x.
2
Comparison of beta-adrenoceptor antagonists as modulators of drug metabolism: effect of lipophilicity on microsomal phase I and II reactions.
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):103S-105S. doi: 10.1111/j.1365-2125.1984.tb02440.x.
3
Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Endocrinology. 1984 Sep;115(3):858-61. doi: 10.1210/endo-115-3-858.
4
Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.
Br J Clin Pharmacol. 1981 Dec;12(6):779-84. doi: 10.1111/j.1365-2125.1981.tb01306.x.
5
Effects of some beta-adrenoceptor blockers on avoidance learning in rats.
Methods Find Exp Clin Pharmacol. 1989 Sep;11(9):535-40.
6
Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs.
Arzneimittelforschung. 1985;35(1A):376-82.
7
Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.
Br J Clin Pharmacol. 1982 Aug;14(2):269-72. doi: 10.1111/j.1365-2125.1982.tb01972.x.
8
alpha 1-Adrenoceptor agonist activity of alpha 2-adrenoceptor antagonists in the pithed rat preparation.
Br J Pharmacol. 1983 May;79(1):12-4. doi: 10.1111/j.1476-5381.1983.tb10488.x.
9
Beta-adrenergic blocking agents: review and update.
Mt Sinai J Med. 1985 Sep;52(7):553-8.
10
Differential relevance of beta-adrenoceptor subtypes in modulating the rat brown adipocytes function.
Arch Int Pharmacodyn Ther. 1995 May-Jun;329(3):436-53.
引用本文的文献
1
beta-blockers. Drug interactions of clinical significance.
Drug Saf. 1995 Dec;13(6):359-70. doi: 10.2165/00002018-199513060-00005.
2
Proceedings of the British Pharmacological Society 8th-10th September, 1982. Abstracts.
Br J Pharmacol. 1982 Dec;77 Suppl(Suppl):445P-597P.
3
Lack of effect of atenolol on antipyrine clearance.
Br J Clin Pharmacol. 1982 Nov;14(5):743-4. doi: 10.1111/j.1365-2125.1982.tb04967.x.
4
Effect of atenolol and metoprolol on the anticoagulant activity of acenocoumarin.
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):94S-96S. doi: 10.1111/j.1365-2125.1984.tb02438.x.
5
Pharmacokinetic and pharmacodynamic interaction study of diazepam and metoprolol.
Eur J Clin Pharmacol. 1984;26(2):223-6. doi: 10.1007/BF00630289.
6
Clinical pharmacokinetics of labetalol.
Clin Pharmacokinet. 1984 Mar-Apr;9(2):157-67. doi: 10.2165/00003088-198409020-00003.
7
The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.
Br J Clin Pharmacol. 1984 May;17(5):553-7. doi: 10.1111/j.1365-2125.1984.tb02389.x.
8
Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.
Br J Clin Pharmacol. 1984 Dec;18(6):853-60. doi: 10.1111/j.1365-2125.1984.tb02555.x.
9
Pharmacology of combined alpha-beta-blockade. I.
Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003.
10
The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin.
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):85S. doi: 10.1111/j.1365-2125.1984.tb02433.x.
本文引用的文献
1
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75.
2
Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Br J Clin Pharmacol. 1980 Oct;10(4):353-61. doi: 10.1111/j.1365-2125.1980.tb01771.x.
3
Effects of metoprolol and propranolol on theophylline elimination.
Clin Pharmacol Ther. 1980 Oct;28(4):463-7. doi: 10.1038/clpt.1980.189.
4
An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents.
J Pharm Pharmacol. 1981 Mar;33(3):172-3. doi: 10.1111/j.2042-7158.1981.tb13743.x.
5
Beta-adrenoceptor blockers and the blood-brian barrier.
Br J Clin Pharmacol. 1981 Jun;11(6):549-53. doi: 10.1111/j.1365-2125.1981.tb01169.x.
6
Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?
Br J Clin Pharmacol. 1981 Apr;11(4):402-6. doi: 10.1111/j.1365-2125.1981.tb01145.x.
7
Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients.
Lancet. 1980 Nov 1;2(8201):978. doi: 10.1016/s0140-6736(80)92135-2.
8
The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man.
J Pharmacol Exp Ther. 1972 Feb;180(2):454-63.
9
Lack of biological interaction of alprenolol and salicylate in man.
Eur J Clin Pharmacol. 1973 Jun;6(1):9-14. doi: 10.1007/BF00561794.
10
Relationship between difference spectra and metabolism. Barbiturates, drug interaction and species difference.
Biochem Pharmacol. 1970 May;19(5):1695-701. doi: 10.1016/0006-2952(70)90160-7.
Zotero 插件